Abstract: When a user attempts to access a first application installed on a user device, it can send an authentication request to an authentication server. The authentication server can assign a unique request token to the request and load a script to a component of the operating system executing on the user device that displays content within the first application. The script can cause a portal application to launch on the user device. The portal application can send a request to the authentication server on behalf of the user, including the unique request token and an access token stored by, or accessible to, the portal application. The authentication server can receive the request from the portal application and validate the request based on the unique request token and the access token. Upon validating the request, the authentication server can authenticate the user at the first application.

Abstract: Two or more computing devices involved in a software based conference are determined. Each computing device of the two or more computing devices has an associated user. An input from a computing device of the two or more computing devices is received. A user action for a user associated with a computing device of the two or more computing devices from the input is determined. Whether the user completed the user action within a threshold is determined. The user is alerted of the user action.

Abstract: When a user attempts to access a first application installed on a user device, it can send an authentication request to an authentication server. The authentication server can assign a unique request token to the request and load a script to a component of the operating system executing on the user device that displays content within the first application. The script can cause a portal application to launch on the user device. The portal application can send a request to the authentication server on behalf of the user, including the unique request token and an access token stored by, or accessible to, the portal application. The authentication server can receive the request from the portal application and validate the request based on the unique request token and the access token. Upon validating the request, the authentication server can authenticate the user at the first application.

Abstract: When a user attempts to access a first application installed on a user device, it can send an authentication request to an authentication server. The authentication server can assign a unique request token to the request and load a script to a component of the operating system executing on the user device that displays content within the first application. The script can cause a portal application to launch on the user device. The portal application can send a request to the authentication server on behalf of the user, including the unique request token and an access token stored by, or accessible to, the portal application. The authentication server can receive the request from the portal application and validate the request based on the unique request token and the access token. Upon validating the request, the authentication server can authenticate the user at the first application.

Abstract: When a user attempts to access a first application installed on a user device, it can send an authentication request to an authentication server. The authentication server can assign a unique request token to the request and load a script to a component of the operating system executing on the user device that displays content within the first application. The script can cause a portal application to launch on the user device. The portal application can send a request to the authentication server on behalf of the user, including the unique request token and an access token stored by, or accessible to, the portal application. The authentication server can receive the request from the portal application and validate the request based on the unique request token and the access token. Upon validating the request, the authentication server can authenticate the user at the first application.

Abstract: The present invention provides a method, system and computer program product for managing one or more processes in an organization. The system enables a user to define various process clusters. The process clusters include various associated processes that are made compliant with a predefined set of standards. Further, the system integrates various process clusters and enables interaction among various processes. Furthermore, the system provides a common access to the process clusters and the associated processes.

Abstract: Cyclooxygenase-2 enzyme inhibiting withanolides are described. In particular, compounds from Withania somnifera are the preferred source of the withanolides, although they can be from other plant sources. The COX-2 inhibition is selective over COX-1.

Abstract: Cyclooxygenase-2 enzyme inhibiting withanolides are described. In particular, compounds from Withania somnifera are the preferred source-of the withanolides, although they can be from other plant sources. The COX-2 inhibition is selective over COX-1.

Abstract: Cyclooxygenase-2 enzyme inhibiting withanolides are described. In particular, compounds from Withania somnifera are the preferred source of the withanolides, although they can be from other plant sources. The COX-2 inhibition is selective over COX-1.

Abstract: Cyclooxygenase-2 enzyme inhibiting withanolides are described. In particular, compounds from Withania somnifera are the preferred source-of the withanolides, although they can be from other plant sources. The COX-2 inhibition is selective over COX-1.

Abstract: Cyclooxygenase-2 enzyme inhibiting withanolides are described. In particular, compounds from Withania somnifera are the preferred source of the withanolides, although they can be from other plant sources. The COX-2 inhibition is selective over COX-1.

Abstract: Cyclooxygenase-2 enzyme inhibiting withanolides are described. In particular, compounds from Withania somnifera are the preferred source of the withanolides, although they can be from other plant sources. The COX-2 inhibition is selective over COX-1.

Abstract: A composition for the treatment of onychomycosis (fungal nail disease) is described. The composition consists essentially of thymol, camphor, menthol and Eucalyptus citridiora as a colorless liquid oil without any carrier or solvent for these ingredients.

Abstract: A method for stimulating insulin secretion by anthocyanidins and anthocyanins is described. The secretion can be in vivo in mammals, including humans, or in vitro.

Abstract: The present invention describes food supplements that contain one or more fruit extracts useful for pain relief and anti-inflammation. The food supplements may be used to inhibit inflammation mediated by cyclooxygenase and more particularly by cyclooxygenase-2.

Abstract: A method for the treatment of obesity, diabetes, high cholesterol and related diseases including hyperglycemia, lipid disorders, hyperglyceridemia, dyslipidemia and atherosclerosis in mammals using anthocyanins, anthocyanidins, ursolic acid and/or betulinic acid is described. Compositions adapted for these treatments are also described.

Abstract: A process for the preparation of hydroxyl substituted anthraquinones is described. The process couples a phthalic anhydride (substituted or unsubstituted) to benzene ring moiety substituted with at least two hydroxyl groups. Remaining hydroxy groups were converted to methoxy groups in some anthraquinones. The compounds are particularly useful for the treatment of parasitic diseases. Also, a method of treating or preventing malaria, filariasis schistosomiasis and other parasitic diseases using anthraquinones.

Abstract: The present invention describes food supplements that contain one or more fruit extracts useful for pain relief and anti-inflammation. The food supplements may be used to inhibit inflammation mediated by cyclooxygenase and more particularly by cyclooxygenase-2.

Abstract: Novel isolated and purified withanamides and withanolides are described. In particular, compounds from Withania somnifera fruit are the preferred source of the withanamides and withanolides, although they can be from other plant sources. In addition to their use as powerful antioxidants, the withanamides and withanolides can be useful for the treatment of depression, Alzheimer's Disease, obesity and migraine headaches.

Abstract: A method for isolating a mixture of anthocyanins, bioflavonoids and phenolics from an edible berry using adsorbent resins which are regenerable for reuse is described. The mixture with a consumable carrier is particularly useful in foods and as a dietary supplement or nutraceutical product.